98%
921
2 minutes
20
Sentinel lymph node biopsy offers a less invasive alternative to full lymphadenectomy in endometrial cancer, reducing complications while maintaining diagnostic accuracy. This case report highlights the integration of holography and augmented reality (AR) in a 34-year-old woman undergoing robotic-assisted surgery for endometrial cancer. Preoperative imaging combined with single-photon emission computed tomography and computed tomography identified sentinel lymph nodes, which were visualized using mixed reality (MR) technology. This approach enabled the surgical team to accurately understand the three-dimensional spatial relationships between lymph nodes and surrounding critical structures. Holographic projections provided precise guidance during surgery, improving lymph node identification and minimizing invasiveness. No lymph node metastasis was detected, but a diagnosis of the International Federation of Gynecology and Obstetrics (FIGO) stage IIIA was confirmed due to tumor seeding in the peritoneum. The patient underwent successful adjuvant chemotherapy with no recurrence observed. This report demonstrates the significant potential of holography and AR to enhance spatial awareness and surgical precision. These technologies represent a promising advancement in sentinel lymph node biopsy for patients with gynecologic cancers, contributing to reduced surgical invasiveness and alleviating stress for surgeons.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830575 | PMC |
http://dx.doi.org/10.7759/cureus.77599 | DOI Listing |
J Bras Pneumol
September 2025
. Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.
Anticancer Drugs
September 2025
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Nonsmall cell lung cancer (NSCLC) with SMARCA4 deficiency represents a rare subset of lung tumors characterized by early metastasis, poor response to chemotherapy, and unfavorable prognosis. Established therapy strategies for SMARCA4-deficient NSCLC remain elusive. While immune checkpoint inhibitors have been proposed as a potential solution, their efficacy remains uncertain.
View Article and Find Full Text PDFInt J Surg
September 2025
Guangxi Medical University, Nanning, Guangxi, China.
Ann Nucl Med
September 2025
Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Objective: This study aims to systematically evaluate the inter- and intra-observer agreement regarding lesions with uncertain malignancy potential in Ga-68 PSMA PET/CT imaging of prostate cancer patients, utilizing the PSMA-RADS 2.0 classification system, and to emphasize the malignancy evidence associated with these lesions.
Methods: We retrospectively reviewed Ga-68 PSMA PET/CT images of patients diagnosed with prostate cancer via histopathology between December 2016 and November 2023.
Ann Surg Oncol
September 2025
Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Background: The optimal number of examined lymph nodes (ELN) for accurate staging and prognosis for esophageal cancer patients receiving neoadjuvant therapy remains controversial. This study aimed to evaluate the impact of ELN count on pathologic staging and survival outcomes and to develop a predictive model for lymph node positivity in this patient population.
Methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and a multicenter cohort.